Schedule 13G ownership disclosure

Zenas Biopharma Inc

Common Stock, par value $0.0001 per share · CUSIP: 98937L105

Event date: 2025-10-07

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • InnoCare Pharma Inc.

    Shares: 5,000,000.00 · Class: 9.4%

  • Ocean Prominent Limited

    Shares: 5,000,000.00 · Class: 9.4%

  • InnoCare Pharma Limited

    Shares: 5,000,000.00 · Class: 9.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-098959
Form type
SCHEDULE 13G
Filer
InnoCare Pharma Inc.
CIK
CIK 2089568
Filed
Oct 15, 2025
Reporting period
Oct 07, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub